FDA-approved Drug Library

Kat.-Nr.L1300

Eine einzigartige Sammlung von 3183 zugelassenen Medikamenten und APIs, die in der Pharmakopöe für Hochdurchsatz-Screening (HTS) und Hochinhalts-Screening (HCS) enthalten sind.

96 well plates

Passen Sie Ihre Bibliothek an:

Zitiert von 698 Publikationen

Beschreibung & Vorteile

• A unique collection of 3183 approved drugs and API included in pharmacopoeia for high throughput screening (HTS) and high content screening (HCS)
 
• All drugs were from approved institutions such as FDA,EMA,HMA,CFDA,PMDA,or pharmacopoeia such as USP,BP,EP,JP,Ph.Int,etc
 
• Provides the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) information of FDA  approved drugs
 
• Locate new targets for old drugs
 
• Bioactivity and safety confirmed by clinical trials
 
• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc
 
• Structurally diverse, medicinally active, and cell permeable
 
• Rich documentation with structure and customer reviews
 
• NMR and HPLC validated to ensure high purity
 
• Here are the approved institutions of approved drugs in this library:
 
Approved institution Full name Country
                FDA U.S. Food and Drug Administration United States of America  
                CFDA China Food and Drug Administration China
                EMA European Medicines Agency European
                HMA Heads Of Medicines Agency European
                NDC National Drug Code United States of America
                PMDA Pharmaceuticals and Medical Devices Agency Japan
                DMF Drug Master File United States of America

 

Produktdetails

Formulierung 2809 compounds pre-dissolved in 10mM DMSO, 271 compounds pre-dissolved in 10mM water, 82 compounds pre-dissolved in 2mM DMSO, 19 compounds pre-dissolved in 2mM water and 2 compounds pre-dissolved in 2mg/ml DMSO
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

FDA-approved Drug Library Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania